Dr. Reddy's shareholders have approved the re-appointment of Mr. G V Prasad as Whole-Time Director, Co-Chairman and Managing Director. This key leadership continuation is for a 5-year term, effective from January 30, 2026, to January 29, 2031. Mr. Prasad, a promoter and seasoned leader with over 36 years in the pharma industry, is vital for driving the company's strategy, innovation, and high corporate governance standards. His re-appointment ensures stability and continuity in steering the company's future direction, which is positive for long-term shareholder value.